Andrew Hall
Vorstandsvorsitzender bei G13r Ltd.
Aktive Positionen von Andrew Hall
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Stone Ridge Ventures Pty Ltd.
Stone Ridge Ventures Pty Ltd. Investment ManagersFinance Stone Ridge Ventures Pty Ltd (Stone Ridge Ventures) is a venture capital firm founded in 2002 by Matthew Callahan and Robert Melville Newman. The firm is headquartered in Balcatta, Australia. | Private Equity Investor | 01.01.2007 | - |
G13r Ltd. | Vorstandsvorsitzender | 01.01.2016 | - |
Gründer | 01.01.2016 | - |
Karriereverlauf von Andrew Hall
Ehemalige bekannte Positionen von Andrew Hall
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Australia'S National Digital Health Initiative
Australia'S National Digital Health Initiative Packaged SoftwareTechnology Services AndHealth is an Australian company that was founded in 2017 by Bronwyn Le Grice. The private company is based in Australia's National Digital Health Initiative. The company aims to provide programs and support to digital health companies in Australia, specifically addressing the challenges of commercializing in this new and emerging sector. Bronwyn Le Grice has been the CEO since incorporation. | Direktor/Vorstandsmitglied | 01.05.2017 | 31.10.2022 |
Founder Institute, Inc.
Founder Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Founder Institute, Inc. provides startup launch programs. Its curriculum include branding and design, product development, and equity and funding. The company was founded by Adeo Ressi and Jonathan Greechan in 2009 and is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | 01.01.2015 | 31.07.2018 |
Inotek Pharmaceuticals Corp.
Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | Berater | 01.01.2005 | 08.01.2018 |
Bright Generation Pty Ltd. | Vorstandsvorsitzender | 01.09.2009 | 31.03.2013 |
Ausbildung von Andrew Hall
The University of Western Australia | Undergraduate Degree |
Wageningen University | Graduate Degree |
Statistik
International
Australien | 5 |
Vereinigte Staaten | 3 |
Vereinigtes Königreich | 2 |
Operativ
Chief Executive Officer | 2 |
Director/Board Member | 2 |
Private Equity Investor | 1 |
Sektoral
Consumer Services | 3 |
Finance | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
Stone Ridge Ventures Pty Ltd.
Stone Ridge Ventures Pty Ltd. Investment ManagersFinance Stone Ridge Ventures Pty Ltd (Stone Ridge Ventures) is a venture capital firm founded in 2002 by Matthew Callahan and Robert Melville Newman. The firm is headquartered in Balcatta, Australia. | Finance |
G13r Ltd. | |
Inotek Pharmaceuticals Corp.
Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | Health Technology |
Australia'S National Digital Health Initiative
Australia'S National Digital Health Initiative Packaged SoftwareTechnology Services AndHealth is an Australian company that was founded in 2017 by Bronwyn Le Grice. The private company is based in Australia's National Digital Health Initiative. The company aims to provide programs and support to digital health companies in Australia, specifically addressing the challenges of commercializing in this new and emerging sector. Bronwyn Le Grice has been the CEO since incorporation. | Technology Services |
Founder Institute, Inc.
Founder Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Founder Institute, Inc. provides startup launch programs. Its curriculum include branding and design, product development, and equity and funding. The company was founded by Adeo Ressi and Jonathan Greechan in 2009 and is headquartered in San Francisco, CA. | Commercial Services |
Bright Generation Pty Ltd. | Industrial Services |
- Börse
- Insiders
- Andrew Hall
- Erfahrung